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Histamine is a biogenic amine, which is involved in a variety of biologic
processes comprising inflammation, allergic responses, neurotransmission and
regulation of gastric acid secretion. The key enzyme for the generation of hist-
amine is histidine decarboxylase (HDC), which converts the amino acid L-his-
tidine to histamine. In this article, we review the history, biochemistry and mol-
ecular biology of this enzyme. Northern blot studies in rats demonstrated that
HDC gene expression in the stomach and liver are developmentally regulated
with highest levels of expression in the late fetal state, indicating a role of the
gene in growth and development. In the stomach ofadult rats, HDC mRNA lev-
els are elevated after omeprazole-induced hypergastrinemia, and in situ
hybridization showed that expression ofHDC is restricted to the glandular area
in which ECL cells are located. Since no permanent ECL cell line is at hand for
in vitro studies, we established a suitable cell system by stable transfection ofa
human gastric adenocarcinoma cell line (AGS) with the CCK-B/gastrin recep-
tor. Transfection ofthis AGS-B cell line with reporter gene constructs compris-
ing 5'-flanking DNA sequence ofthe HDC genejoined to the firefly luciferase
gene revealed transcriptional regulation of the HDC promoter by gastrin
through a protein-kinase C-dependent pathway. Taken together, these studies
are consistent with the concept ofHDC transcriptional regulation as at least one
phase ofthe overall response to gastrin.
I. INTRODUCTION TO HISTAMINE AND HISTIDINE DECARBOXYLASE
Since the first description ofits physiologic actions by Dale and Laidlaw in 1910 [1],
histamine has been shown to play a number of biologic functions, including roles in
inflammation, allergic responses, neurotransmission, and growth and repair [2]. However,
particular attention has been given to its role as a gastric secretogogue. An important
breakthrough occurred with the discovery by Black and co-workers that histamine-2
receptorantagonists potently inhibit acid secretion [3]. More recent studies have now con-
firmed that histamine represents the final common pathway in the stimulation of acid
secretion. The secretion of histamine by the enterochromaffin-like (ECL)b cell under-
scores the importance ofthis gastric endocrine cell in the overall physiology of the stom-
ach, and has generated greater interest in the molecular mechanisms ofhistamine produc-
tion. Histamine is generated in the stomach through the action of the enzyme histidine
decarboxylase (HDC), which decarboxylates the amino acid L-histidine (Figure 1), lead-
ing to the production and release ofCO2 that can be readily measured. The enzyme histi-
dine decarboxylase is present in a variety ofcell types, including mast cell, skin, platelets
and basophils, but in the adult mammal (e.g., rat) it is found at high levels in gastric ECL
cells [2]. This article will review the discovery ofhistidine decarboxylase, the cloning of
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Figure 1. Histidine decarboxylase converts L-histidine to L-histamine by decarboxylation.
the cDNAs and genes for HDC and recent work that has explored the regulation ofHDC
gene expression.
H. HISTORY OF HISTIDINE DECARBOXYLASE
The role of histamine as a stimulant of acid secretion has been known since the ini-
tial work by Popielsky dating back to 1920 [4]. However, the importance ofhistamine as
the key physiologic mediator was not widely appreciated until more recently, when stud-
ies by Kahlson and Code in the 1960s [5, 6], the discovery ofH2 receptor antagonists by
Black in the 1970's [3] and more recent in vivo and in vitro models over the last decade
have highlighted the importance of histamine secretion as the final common pathway of
acid secretion. Studies in amphibians [7], rabbits [8], rats [9] and humans [10, 11] have
now demonstrated that gastrin stimulates gastric acid secretion mainly through therelease
of histamine. In isolated perfused rat stomachs, gastrin is able to stimulate histamine
release followed later by acid secretion [12], and the response is completely inhibited by
H2 blockers or diamine oxidase [13].
The source ofhistamineproduction in the stomach was apointofcontention formany
years. Although the possibility ofmast cell-derived histamine as a source was considered
initially, attention eventually shifted to an endocrine cell located in the glandularregion of
the gastric fundus. The ECL cells were first recognized in the stomach using light
microscopy and argyrophilic staining techniques (Grimelius and Sevier-Munger) that
included exogenic reducing agents, which stained not only ECL cells, but other endocrine
cells (EC) cells as well [14]. Evidence that the ECL cell synthesizes and stores histamine
was first reported by Hakanson and et al. [15], and further studies identified ECL cells in
the oxyntic mucosa of a broad range ofvertebrate species [15]. In response to acute gas-
trin stimulation, ECL cells respond with histamine release, leading to a depletion ofhist-
amine stores. With chronic gastrin stimulation, proliferation ofECL cells occurs, leading
to ECL cell hyperplasia andeventually ECL cell carcinoid tumors [16]. However, an inter-
mediate response was also recognized, which was characterized by an increase in HDC
activity leading to repletion ofhistamine stores.
The presence of a histidine decarboxylating enzyme in mammalian tissue was first
reportedbyWerle when hediscovered that slices ofrabbitkidney formed histamine from
histidine [17]. The stimulation of HDC enzymatic activity in response to feeding and
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gastrin stimulation was first described by Kahlson et al. in 1964 [5]. Subsequently, a
number ofstudies carried out in rodents by Hakanson and others demonstrated good cor-
relations between increases in plasma gastrin levels and gastric HDC activity [16]. These
increases were reversed by reductions in serum gastrin levels accomplished through sur-
gical antrectomy. In humans, elevations of HDC activity and fundic histamine content
have been reported in patients with atrophic gastritis and hypergastrinemia [18, 19]. In
vitro studies demonstrated that gastrin is able to induce increases in HDC activity in
highly purified ECL cell preparations derived from rabbits [20] or rats [21]. The induc-
tion of HDC enzymatic activity in these preparations is dose-dependent and occurs
through direct activation of the CCK-B/gastrin receptor. Since maximal responses (10-8
M gastrin) in both preparations were observed within 30-60 min, the rapidity of the
response raised the question as to whether the increase in HDC activity was due to the
synthesis of new enzyme or activation of stored forms. Histidine decarboxylase in the
rat hypothalamus and lung have been shown to be activated by effects ofprotein kinase
A [22]. In addition, one study demonstrated that HDC activity can be altered by phos-
phorylation, which could provide a regulatory mechanisms for activation of cellular
stores of the HDC enzyme [23]. However, the effect of gastrin on HDC synthesis and
gene expression awaited further advances in molecular biology and the cloning of the
HDC gene.
HI. ISOLATION AND CHARACTERIZATION OF THE HDC GENE
A number of groups were successful early on in the partial purification of the histi-
dine decarboxylase protein. Watanabe and Taguchi purified HDC from fetal rat liver and
reported that the enzyme was adimer of54 kDa subunits with apl of5.1 [24, 25]. Several
other groups were also successful in partially purifying the enzyme from rat gastric
mucosa [26], rat basophilic leukemia cells [27] and mouse mastocytoma cell lines [28].
However, Joseph et al. were the first group to successfully clone a cDNA for histidine
decarboxylase [29]. During their studies on androgen binding proteins, they isolated the
rat HDC cDNA from a fetal liver library. The cDNA clone was found to encode a 655
amino acidprotein that was 50 percent homologous to ratdopadecarboxylase. The cDNA
predicted a protein with two potential glycosylation sites and two consensus sites for
phosphorylation. The molecular weight of the deduced protein (73 kDa) was significant-
ly larger than the two 55 kDa subunits believed to form the dimer, suggesting post-trans-
lational processing [29]. Subsequently, the cDNA's for HDC were cloned from mouse
mastocytoma cells [30], human basophilic leukemia KU-812-F cells [31] and human ery-
throleukemia cells [32]. The human and mouse clones were found to encode proteins of
662 amino acids, and the sequences were 85 percent homologous with rat liver HDC. In
addition, the human HDC gene has been mapped to a gene locus on chromosome 15 [32].
Northern blot analysis showed two types of HDC transcripts (2.7 and 3.5 kb) in rat liver
and rat corpus [29, 33] and two types ofHDC transcripts (2.4 kb and 3.4 kb) in KU-812-
F human basophilic leukemia cells [3]. Studies carried out with human basophilic
leukemia cells demonstrated that the different sized transcripts arose from alternative
splicing ofthe human HDC gene and that only the 2.4 kb mRNA encodes for functional
HDC [34].
IV. TISSUE SPECIFIC EXPRESSION OF HDC
Early studies by Kahlson et al. demonstrated that the fetal rat contained high concen-
trations ofHDC activity, with large increases seen atthe 15thday ofpregnancy and climb-
ing to a peak in the last one to two days before term, followed by a precipitous decline at
the time ofbirth [5]. Interestingly, despite the high rate ofhistamine production in the rat
23Hocker et al.: Regulation ofhistidine decarboxylase
fetus, the actual concentration of histamine was lower in the rat fetus than in the adult, a
factor that was attributed to decreased histamine binding and rapid turnover. Most of the
fetal HDC activity was localized to the liver, which overall accounted for 80 percent ofthe
HDC activity in the fetus. The fetal stomach and lung demonstrated lower levels ofHDC
activity compared to the liver, but in general, all fetal tissues exhibited HDC activity that
was quitehigh when compared to that observed in neonatal and adult animals. In the adult
rat, HDC activity was lower with a somewhat different distribution. Significant activity
was detected in the adult stomach, with lower levels seen in the lung, liver and kidney [5].
Other investigators have confirmed that the most abundant source of HDC and HDC
mRNA is in the fetal rat liver, the tissue from which the cDNA sequence was originally
detected. Taguchi et al., for example, noted that the fetal rat liver contains about 75 per-
cent ofthe total level of HDC [25].
Apart from the stomach, the identity of the cells that express HDC remain unclear.
Most mammalian tissues that have been studied have been found to express some HDC
activity, albeit at low levels. Although mast cells express HDC and are present in many
organs, histamine is apparently synthesized by cells other than mast cells. With respect to
the liver, it was initially felt that the HDC-expressing cell was ofnon-mast-cell origin [5].
However, studies by Watanabe et al. showed that embryos from genetically mast cell defi-
cientW/Wv mice lacked the usual increase in hepatic HDC activity demonstrated by nor-
mal fetuses at the time of birth [35]. A more recent study by Ohmuri et al. suggests that
the HDC-expressing cells in the fetal liver may be mast cell precursors but not mast cells
[36]. In addition, the study by Ohmuri et al. provided evidence for possible regulation of
fetal hepatic HDC by the plasma glucocorticoid level through the pituitary-adrenal sys-
tem. This glucocorticoid regulatory mechanism may apply as well to mouse mastocytoma
P-815 cells [37] and the rat glandular stomach [38].
In order to investigate the tissue specific expression of the HDC gene in the rat, we
carried out a series of Northern blots, using a panel of total RNA prepared from day-19
rat fetuses, as well as from adult (> 6 weeks) rats. In fetal rats, the liver could be identi-
fied as the organ with highest levels of HDC expression, the stomach and pancreas were
also positive, but displayed lower levels ofHDC gene expression (Figure 2). In adult ani-
mals, liver, corpus and pancreas were the only organs in which HDC expression could be
detected (Figure 2); the highest levels ofHDC mRNA abundance were found in the liver,
lower expression was found in the gastric corpus and the pancreas. These findings are in
contrast to early reports ofKahlson et al. [5] who found in the stomach ofadult rats high-
er HDC enzymatic activity than in the liver.
To analyze the developmental regulation ofthe HDC gene in liver and stomach, total
RNA was isolated from unborn rats at day 19 ofgestation and from newborn rats at vari-
ous timepoints afterdelivery. In both organs an identical pattern ofHDC expression could
be found: HDC mRNA could be detected atday 19 offetal development while no expres-
sion of the gene was detectable at days one, three and five after birth. HDC mRNA was
seen again atday seven afterdelivery, and reached maximal levels after additional 21 days
(Figure 3).
V. POSSIBLE ROLE OF HDC EXPRESSION IN
GROWTH AND REGENERATION
The role ofHDC and histamine in the fetus, and in adult tissues aside from ECL and
mast cells, is not well understood. The possibility that histamine may play a significant
role in cellular proliferation and tumor growth was first suggested over 30 years ago by
Kahlson et al. [39]. These investigators initially observed that, using a combination of
pyridoxine deficiency and a small dose of semicarbazole, they were able to lower HDC
activity to 20 percent ofnormal. As a consequence, fetal growth was arrested, and the rat
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Figure 2: Northern blot analysis ofHDC expression in various tissues offetal and adult rats.
Total RNA was prepared as previously described and 20gg total RNA/lane were electrophoresed in
an one percent formaldehyde/agarose gel under denaturing conditions. Following Northern transfer,
filters were hybridized with a radiolabeled 354 bp antisense RNA probe complementary to the 3'
end of the rat HDC cDNA and autoradiography was performed for 24 hr. 20 jg of total RNA pre-
pared from fetal rat liver was used as a positive control. Positions of 28s and 18s ribosomal RNA's
are indicated by arrows.
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Figure 3. Northern blot analysis ofHDC expression in stomach (left) and liver (right) offetal
rats and at various time points after birth. Total RNA was prepared from unborn rats at day 19
of pregnancy and at day 1, day 3, day 5, day 7 and day 28 after delivery. Twenty jg of total RNA
per lane were electrophoresed under denaturing conditions in an formaldehyde/agarose gel, trans-
ferred to nylon membrane and hybridized with a radiolabeled 354 bp antisense RNA probe, com-
plementary to the 3' end ofthe rat HDC cDNA. Twenty jg oftotal RNA prepared fetal rat liver was
used as a positive control. Positions of 28s and 18s ribosomal RNA's are indicated by arrows.
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fetus died [40]. In addition, rat liver tissue regenerating after partial hepatectomy displays
a substantially elevated HDC activity [41, 42]. HDC activity is also raised in the tissue of
healing skin wounds [41], mouse skin after application of tumor promoters [43] and in
experimental tumors [44, 45]. Exposure ofrats to restraint and cold-induced stress results
in formation of gastric ulcerations and simultaneous elevations ofgastric and hypothala-
mic HDC activity. The extent ofmucosal lesions was diminished by 70percent afterappli-
cation ofan H2 blocker orby inhibition ofHDC activity by treatment witha-flouromethyl
histidine (a-FMH) - a specific irreversible inhibitor of HDC, indicating that increased
HDC activity is playing a role in the formation oflesions in the rat [46]. The same com-
pound has been used to assess the role of HDC in tumor growth in different systems.
Hosoda et al. showed that when a-FMH was given (by i.p. injection or continuous sub-
cutaneous infusion) to an African rodent (Mastomys natalensis) bearing transplanted gas-
tric carcinoids, it resulted in a decrease in histamine production and a reduction in tumor
size [47]. Thus, in addition to being markedly stimulated in the setting ofgrowth and pro-
liferation, HDC activity may actually contribute to the growth state. The mechanism by
which histamine or HDC stimulate cellular proliferation remains unclear, although the
possibility has recently been raised that histamine may be acting through intracellular
receptors [2, 48]. In addition, Fujimoto et al. have shown that HDC, and ODC, activity
increase during mucosal repair in the small intestine after ischemia-reperfusion. Based on
studies using a-FMH, they concluded that enzymatically active HDC is necessary for
restoration of mucosal function and that this is mediated in part by stimulation of ODC
activity [49]. A relationship between stimulation of HDC and ODC activity is also sup-
ported by earlier studies showing that both HDC and ODC activity in the colon are stim-
ulated by phorbol esters such as 12-o-tetradecanoylphorbol-13-acetate [50].
VI. REGULATION OF HDC mRNA ABUNDANCE IN THE
STOMACH BY GASTRIN - INVIVO MODELS
Early studies carried out in rats established the concept that gastrin acts to control
HDC mRNA abundance. Initial experiments by Dimaline et al. showed that fasting rats
for 48 hr led to reductions in circulating gastrin concentrations and reductions (by 70 per-
cent) in corpus HDC mRNA levels [33]. Omeprazole treatment offasted rats led to hyper-
gastrinemia (eight to ten-fold) and significant (three-fold) elevations in HDC mRNA
abundance compared to fasted controls. The effect ofomeprazole on HDC mRNA abun-
dance could be blocked by specific CCK-B/gastrin receptor antagonists, such as PD
134308. In contrast, omeprazole treatment offed rats did not result in significant stimula-
tion ofHDC mRNA levels [33]. A subsequent study in rats by Sandvik et al. showed that
infusion ofexogenous gastrin also led to increases in HDC activity and mRNA levels at 2
hr, although the increases were small [51].
However, these early studies did not analyze the time-course for changes in HDC
expression afterelevation ofendogenous plasmagastrin levels. Further, they did notlocal-
ize these changes in HDC gene expression to specific regions of the gastric mucosa.
Therefore, to address these questions, we administered omeprazole (400mmollkg) to fast-
ed rats, and analyzed plasma gastrin levels by radioimmune assay and corpus HDC
mRNA levels using both Northern blot and in situ hybridization analysis [52]. Within 12
hr after a single injection ofomeprazole, serum gastrin levels increased 5.5-fold and HDC
mRNA levels increased by 4.4-fold. Since earlier studies showed that hypergastrinemia
occurs within two to eight hr after a single i.p. injection ofomeprazole, this implies arel-
atively short time span (4 to 10 hr) for the activation ofHDC gene expression in response
to gastrin. Finally, the stimulation ofHDC mRNA abundance could be localized by in situ
hybridization studies to the basal third of the oxyntic glands, consistent with the known
location ofECL cells. The signal was much greater in omeprazole treated rats, compared
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to controls (Figure 4). No stimulation of HDC expression could be detected in the lami-
nal propria, were mucosal mast cells are typically located [52]. Thus, these studies sup-
port the concept of a rapid, gastrin-dependent increase in HDC gene expression that
occurs specifically in gastric epithelial cells - presumably ECL cells - that are located
in the basal third ofthe oxyntic glands.
VII. REGULATION OF HDC ACTIVITY AND mRNAABUNDANCE
IN MAST CELL/BASOPHILIC LEUKEMIA CELLS IN VITRO
Initial work examining HDC activity and mRNA abundance in vitro was carried out
in cell lines derived from mastocytomas or basophilic leukemia cells. Rat basophilic
leukemia (RBL-2H3) cells were shown to exhibit histidine decarboxylase activity, which
was stimulated by higher oligomeric IgE or phorbol myristate acetate [53]. The histidine
decarboxylase activity in the human basophilic leukemia cell line (KU-812-F) was also
found to be high, could be stimulated by phorbol ester, and its induction was blocked by
the protein kinase C inhibitor staurosporine [54]. The mouse mastocytoma cell line (P-
815) was shown to contain HDC activity and Northern blot analysis also demonstrated
expression ofHDC mRNA. Levels ofHDC mRNA in P-815 cells were increased by dex-
amethasone, and TPA treatment had a synergistic effect in combination with dexametha-
sone [55]. HDC mRNA levels in P-815 cells were also increased by a combination of
cyclic AMP and the Ca2+ ionophore A23187 [56]. Finally, phorbol ester treatment of P-
815 cells stimulated binding to a phorbol ester-response element by a nuclear factor
extracted from the mastocytoma cells, which most likely represents transcription factor
AP-l activity [57].
VIII. REGULATION OF HDC TRANSCRIPTION IN GASTRIC
CELLS BY GASTRIN - INVITRO MODELS
In order to study the molecular mechanism governing the HDC transcriptional
response to gastrin, we turned to an in vitro cell culture system. Since no permanent ECL
cell line is yet available, a gastric cancer cell line (AGS) was stably transfected with the
human CCK-B/gastrin receptor to generate the AGS-B cell line. The presence of func-
tionally intactCCK-B/gastrin receptors inAGS-B cells was confirmed by binding studies,
Northern blot analysis, and [Ca2+]i measurements after gastrin stimulation [52]. A
reporter gene construct was created, which consisted of 1.2 kb of rat HDC 5'-flanking
DNA (plus 67 nucleotides of the non-coding portion of exon I), joined to the firefly
luciferase reporter gene in the plasmidpXP2. When transfected into plainAGS cells (lack-
ing CCK-B/gastrin receptors), no response to gastrin stimulation was seen. When the rat
1.2 kb HDC-luciferase construct was transfected into AGS-B cells, a dose-dependent
increase in reporter gene (luciferase) activity was seen in response to stimulation with the
CCK-B/gastrin receptor-specific agonists gastrin or CCK-8. Maximal increases (three to
four-fold) were seen with 10-7 M gastrin or CCK-8. The effects of gastrin and CCK-8
could be blocked by the CCK-B/gastrin receptor- specific antagonist L 365,260 and the
CCK-A receptor-specific antagonist L 364,718 with typical difference in their IC50 con-
centrations [52]. Time-course studies demonstrated that in continuous presence of5x10-7
M gastrin maximal stimulation occurred after 12 hr. After a4-hr gastrin pulse-exposure to
gastrin, maximal activation of the HDC promoter was seen 6 to 8 hr after the end of the
gastrin treatment. Finally, deletion analysis indicated that the gastrin response element
was located in the rat HDC gene within 201 nucleotides ofthe translational start site, and
thus very close to the basal rat HDC promoter [52]. Overall, these in vitro studies with the
AGS-B cell line transfected with the ratHDC-luciferase constructs are consistent with our
in vivo data, supporting the concept of a gastrin-induced transcriptional response of the
HDC gene being mediated by specific DNA sequences located in the rat HDC promoter.
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IX. SIGNAL TRANSDUCTION PATHWAYS
REGULATING HDC GENE EXPRESSION
Using the AGS-B cell system, it has been possible to begin to examine the signal
transduction pathways that are activated in response to gastrin stimulation, and which may
be mediating transcriptional responses such as activation of the HDC gene. The respons-
es to gastrin are mediated by the CCK-B/gastrin receptor, which was recently cloned and
shown to be a seven transmembrane domain, G-protein coupled receptor [58]. Previous
studies using transfected COS-7 cells or chinese hamster ovary cells demonstrated that
stimulation of the recombinant human CCK-B/gastrin receptor leads to elevation of
[Ca2+]i and induction ofprotein kinase C translocation, consistent with activation ofphos-
pholipase C pathways [58-60].
Using our system ofAGS-B cells transfected with rat HDC-luciferase constructs, we
have been able to show that gastrin activates HDC transcription through aprotein kinase C-
dependent pathway. Using the phorbol ester PMA, we showed thatdirect activation ofpro-
tein kinase C also stimulated rat HDC promoter activity in a dose-dependent fashion [52].
Stimulation of rat HDC promoter activity by either gastrin or PMA could be blocked by
downregulation ofprotein kinase C (using prolong phorbol ester pretreatment) or through
the use of non-toxic doses of a protein kinase C-specific protein kinase antagonist (H-7).
Induction of Ca2+-dependent signaling pathways with thapsigargin did not significantly
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Figure 5. Stimulation of rat HDC promoter activity by gastrin, thapsigargin, forskolin, dibu-
tyryl-cAMP or the phorbolester PMA. AGS-B cells transiently transfected with the 1.2 kb rHDC-
luc reporter construct were incubated with gastrin (5x10-8 M), thapsigargin (10-6 M), forskolin (104
M), db-cAMP (10-3 M) or PMA (10-8 M). Transfected cells were incubated with stimuli for appropi-
ate time spans and cells lysates were assayed for luciferase activity. Results were expressed as
increase ofluciferase activity detected in unstimulated controls. Values represent means + SD offour
independent experiments.
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induce HDC promoter activity (Figure 5). We also found that the rat HDC promoter could
be activated by stimulation ofprotein kinaseA-dependentpathways, usingdibutyryl-cAMP
or forskolin (Figure 5) [52]. As yet, however, there has been no clear link between the
CCK-B/gastrin receptor and protein kinaseA pathways, although this stimulatory pathway
may represent a potential regulatory mechanism for some other receptor/ligand system.
X. OTHER POTENTIAL REGULATORS OF HDC GENE EXPRESSION
ECL cells play a central role in the peripheral regulation ofacid secretion. In addition
to being regulated by gastrin, ECL cells respond to a number ofother hormones and neu-
rotransmitters. Studies using highly enriched and purified rat ECL cells in culture have
demonstrated that ECL cells respond not only to gastrin but also to carbachol, somato-
statin, and histamine stimulation [20, 21]. Carbachol, like gastrin, stimulates ECL cells to
release histamine and elevates HDC enzymatic activity. Somatostatin has been shown to
inhibit gastrin-mediated histamine release. Histamine may exert a negative feedback con-
trol on the secretion of histamine by ECL cells, since a specific agonist for the H3 recep-
tor subtype (R-methyl-histamine) inhibits, and the H3 receptor antagonist thioperamide
potentiates gastrin stimulated histamine release [21].
Although the role of carbachol, somatostatin, and histamine in regulating HDC gene
expression has not yet been examined directly, it is likely that they may play a role in this
regard. HDC mRNA abundance is clearly regulated by food stimulation; fasting in the rat
leads to areduction in HDC mRNA abundance, while refeeding induces arapid increase in
HDC mRNA, often within 30 min offeeding, which is not reduced by neutralizing gastrin
antibodies [51]. The possible role of direct vagal stimulation in regulating HDC activity
was raised initially in early studies by Lundell et al. [61]. More recently, it has been shown
that HDC mRNA is also increased in the rat oxyntic mucosa by passive distention of the
stomach [62]. Thus, at present, there is supportive data which suggest that the response of
HDC mRNA to feeding may be mediated by a cholinergic muscarinic reflex.
XI. CONCLUSIONS AND FUTURE STUDIES
Although the studies by our group and those of other labs clearly demonstrate stimu-
lation ofHDC gene expression by gastrin, these observations do not exclude the possibil-
ity that other levels of HDC activation may be operating in vivo, including that of direct
activation of HDC enzymatic activity by post-translational modification of pre-formed
protein. Experimental evidence for this mechanism was provided by a study using puri-
fied ECL cells from rabbits, which suggested that both gastrin and carbachol may increase
HDC activity in a manner independent from increases in transcription or translation [20].
However, our data have now clearly established a role of transcriptional control of HDC
by gastrin. In addition, ourAGS-B cell model now provides the opportunity for a detailed
examination of the molecular mechanisms regulating HDC gene expression in the stom-
ach. Using this system, it may be possible to delineate the signal transduction pathways
and transcription factors activated by gastrin which regulate HDC gene expression. These
studies may also provide insights into the gastrin-dependent pathways involved in other
processes, including the regulation ofcellular proliferation.
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